BIOMAT Database Logo BIOMAT Database Logo

The relationship between c-erbB-2 expression, S-phase fraction and prognosis in breast cancer. 1991

S M O'Reilly, and D M Barnes, and R S Camplejohn, and J Bartkova, and W M Gregory, and M A Richards
ICRF Clinical Oncology Unit, Guy's Hospital, London, UK.

The relationship between c-erbB-2 gene expression (assessed immunohistochemically), S-phase fraction (SPF) and prognosis has been analysed in 172 women with primary breast cancer. c-erbB-2 staining was independent of age, tumour size, number of nodes involved, tumour grade and DNA ploidy, but was more common in oestrogen receptor (ER) negative tumours (P = 0.02) and progesterone receptor (PgR) negative tumours (P = 0.03). A weak correlation between c-erbB-2 staining and SPF was observed (r = 0.18). Amongst women with node negative disease, SPF was significantly related to relapse free survival (RFS, P = 0.04) while c-erbB-2 staining was not (P = 0.2). In contrast, both SPF (P = 0.002) and c-erbB-2 staining (P = 0.016) provided significant prognostic information on RFS for women with node positive disease. Multivariate analysis showed that c-erbB-2 staining and SPF gave independent information on RFS for women with node positive disease.

UI MeSH Term Description Entries
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D011518 Proto-Oncogene Proteins Products of proto-oncogenes. Normally they do not have oncogenic or transforming properties, but are involved in the regulation or differentiation of cell growth. They often have protein kinase activity. Cellular Proto-Oncogene Proteins,c-onc Proteins,Proto Oncogene Proteins, Cellular,Proto-Oncogene Products, Cellular,Cellular Proto Oncogene Proteins,Cellular Proto-Oncogene Products,Proto Oncogene Products, Cellular,Proto Oncogene Proteins,Proto-Oncogene Proteins, Cellular,c onc Proteins
D011519 Proto-Oncogenes Normal cellular genes homologous to viral oncogenes. The products of proto-oncogenes are important regulators of biological processes and appear to be involved in the events that serve to maintain the ordered procession through the cell cycle. Proto-oncogenes have names of the form c-onc. Proto-Oncogene,Proto Oncogene,Proto Oncogenes
D001943 Breast Neoplasms Tumors or cancer of the human BREAST. Breast Cancer,Breast Tumors,Cancer of Breast,Breast Carcinoma,Cancer of the Breast,Human Mammary Carcinoma,Malignant Neoplasm of Breast,Malignant Tumor of Breast,Mammary Cancer,Mammary Carcinoma, Human,Mammary Neoplasm, Human,Mammary Neoplasms, Human,Neoplasms, Breast,Tumors, Breast,Breast Carcinomas,Breast Malignant Neoplasm,Breast Malignant Neoplasms,Breast Malignant Tumor,Breast Malignant Tumors,Breast Neoplasm,Breast Tumor,Cancer, Breast,Cancer, Mammary,Cancers, Mammary,Carcinoma, Breast,Carcinoma, Human Mammary,Carcinomas, Breast,Carcinomas, Human Mammary,Human Mammary Carcinomas,Human Mammary Neoplasm,Human Mammary Neoplasms,Mammary Cancers,Mammary Carcinomas, Human,Neoplasm, Breast,Neoplasm, Human Mammary,Neoplasms, Human Mammary,Tumor, Breast
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013534 Survival Continuance of life or existence especially under adverse conditions; includes methods and philosophy of survival.
D015999 Multivariate Analysis A set of techniques used when variation in several variables are studied simultaneously. In statistics, multivariate analysis is interpreted as any analytic method that allows simultaneous study of two or more dependent variables. Analysis, Multivariate,Multivariate Analyses
D016196 S Phase Phase of the CELL CYCLE following G1 and preceding G2 when the entire DNA content of the nucleus is replicated. It is achieved by bidirectional replication at multiple sites along each chromosome. S Period,Period, S,Periods, S,Phase, S,Phases, S,S Periods,S Phases
D018719 Receptor, ErbB-2 A cell surface protein-tyrosine kinase receptor that is overexpressed in a variety of ADENOCARCINOMAS. It has extensive homology to and heterodimerizes with the EGF RECEPTOR, the ERBB-3 RECEPTOR, and the ERBB-4 RECEPTOR. Activation of the erbB-2 receptor occurs through heterodimer formation with a ligand-bound erbB receptor family member. HER-2 Proto-Oncogene Protein,Proto-Oncogene Protein HER-2,Proto-Oncogene Protein p185(neu),c-erbB-2 Protein,erbB-2 Proto-Oncogene Protein,erbB-2 Receptor Protein-Tyrosine Kinase,neu Proto-Oncogene Protein,Antigens, CD340,CD340 Antigen,Erb-b2 Receptor Tyrosine Kinases,Metastatic Lymph Node Gene 19 Protein,Neu Receptor,Oncogene Protein HER-2,Proto-Oncogene Proteins c-erbB-2,Proto-oncogene Protein Neu,Receptor, Neu,Receptors, erbB-2,Tyrosine Kinase-type Cell Surface Receptor HER2,p185(c-neu),p185erbB2 Protein,CD340 Antigens,Erb b2 Receptor Tyrosine Kinases,ErbB-2 Receptor,HER 2 Proto Oncogene Protein,Oncogene Protein HER 2,Proto Oncogene Protein HER 2,Proto Oncogene Proteins c erbB 2,Proto-Oncogene Protein, HER-2,Proto-Oncogene Protein, erbB-2,Proto-Oncogene Protein, neu,Tyrosine Kinase type Cell Surface Receptor HER2,c erbB 2 Protein,erbB 2 Proto Oncogene Protein,erbB 2 Receptor Protein Tyrosine Kinase,erbB-2 Receptors,neu Proto Oncogene Protein

Related Publications

S M O'Reilly, and D M Barnes, and R S Camplejohn, and J Bartkova, and W M Gregory, and M A Richards
Association of c-erbB-2 expression and S-phase fraction in the prognosis of node positive breast cancer.
January 1991, Annals of oncology : official journal of the European Society for Medical Oncology,
S M O'Reilly, and D M Barnes, and R S Camplejohn, and J Bartkova, and W M Gregory, and M A Richards
Relationship between c-erbB-2 and other tumor characteristics in breast cancer prognosis.
December 2000, Clinical cancer research : an official journal of the American Association for Cancer Research,
S M O'Reilly, and D M Barnes, and R S Camplejohn, and J Bartkova, and W M Gregory, and M A Richards
c-erbB-2/neu protein expression, DNA ploidy and S phase in breast cancer.
July 1996, Cell proliferation,
S M O'Reilly, and D M Barnes, and R S Camplejohn, and J Bartkova, and W M Gregory, and M A Richards
[Prognosis prediction of S-phase fraction and p53, c-erbB-2, estrogen receptor, progesterone receptor in axillary node-negative breast cancer].
August 1997, Zhonghua wai ke za zhi [Chinese journal of surgery],
S M O'Reilly, and D M Barnes, and R S Camplejohn, and J Bartkova, and W M Gregory, and M A Richards
c-erbB-2 expression in primary breast cancer.
January 1999, The International journal of biological markers,
S M O'Reilly, and D M Barnes, and R S Camplejohn, and J Bartkova, and W M Gregory, and M A Richards
[Relationship between c-erbB-2 oncoprotein expression and prognosis in salivary gland malignant pleomorphic adenoma].
November 1995, Zhonghua kou qiang yi xue za zhi = Zhonghua kouqiang yixue zazhi = Chinese journal of stomatology,
S M O'Reilly, and D M Barnes, and R S Camplejohn, and J Bartkova, and W M Gregory, and M A Richards
Relationship between c-erbB-2 protein product expression and response to endocrine therapy in advanced breast cancer.
January 1992, British journal of cancer,
S M O'Reilly, and D M Barnes, and R S Camplejohn, and J Bartkova, and W M Gregory, and M A Richards
The relationship between c-erbB-2 oncogene expression and clinicopathological factors in gastric cancer.
January 1999, The Journal of international medical research,
S M O'Reilly, and D M Barnes, and R S Camplejohn, and J Bartkova, and W M Gregory, and M A Richards
[The relationship between C-erbB-2 expression with cell proliferative activity and prognosis of nasopharyngeal carcinomas].
January 1998, Hunan yi ke da xue xue bao = Hunan yike daxue xuebao = Bulletin of Hunan Medical University,
S M O'Reilly, and D M Barnes, and R S Camplejohn, and J Bartkova, and W M Gregory, and M A Richards
Relationship between EGF-R, c-erbB-2 protein expression and Ki67 immunostaining in breast cancer and hormone sensitivity.
January 1993, European journal of cancer (Oxford, England : 1990),
Copied contents to your clipboard!